Pulmonary and Sleep Specialists in Michigan

Pulmonary Alveolar Proteinosis Doctor in Michigan

Pulmonary Alveolar Proteinosis Doctor in Oakland County and Wayne County Michigan

What is Pulmonary Alveolar Proteinosis?

Alveolar proteinosis (AP) is a rare, complex pulmonary disorder characterized by the accumulation of protein-rich material in the alveoli of the lungs. This condition affects the ability of the lungs to transfer oxygen effectively to the bloodstream, leading to respiratory symptoms and complications.

How is alveolar proteinosis diagnosed?

Alveolar proteinosis is often challenging to diagnose due to its nonspecific symptoms. A definitive diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. The gold standard for AP diagnosis is the bronchoalveolar lavage (BAL) test, which allows the identification of characteristic foamy exudate within the alveoli.

Dr. Asker Asmi, MD is a certified pulmonologist, and sleep disorders doctor in Michigan

Social Links:
Dr. Asmi’s Beaumont Hospital Page
Dr. Asmi’s Henry Ford Profile Page

Dr. Asmi is a Pulmonologist and sleep specialist based in Michigan that specializes in advanced COPD. He follows a multidisciplinary treatment plan that includes nutrition, medicine, lifestyle changes, damage prevention and active treatment with close follow up. Doctor Asmi’s expertise include Critical Care Medicine, Pulmonary Medicine, Pulmonary Critical Care and Sleep Medicine. Dr. Asmi is also affiliated with Beaumont Hospital and runs a private practice in Riverview, MI.

What are the symptoms of alveolar proteinosis?

The symptoms of alveolar proteinosis can vary from mild to severe and may include:

  • Shortness of breath or dyspnea.
  • Dry cough.
  • Chest pain.
  • Fatigue.
  • Fever and weight loss (in advanced cases).

What causes alveolar proteinosis?

Alveolar proteinosis can be primary or secondary. Primary AP is an idiopathic condition with unknown causes, accounting for about 25% of all cases. Secondary AP results from various underlying conditions such as infections, malignancies, autoimmune disorders, and certain medications.

How is alveolar proteinosis treated?

Alveolar proteinosis treatments focus on removing the protein-rich material within the alveoli to improve lung function. The primary treatment options include:

Granulocyte-macrophage colony-stimulating factor (GM-CSF): This medication helps stimulate the production of white blood cells, which in turn promote the clearance of lipoproteinaceous material from the alveoli.

Whole lung lavage (WLL): A procedure involving the instillation and subsequent removal of a large volume of saline solution through a bronchoscope to wash out the protein-rich material within the lungs.

Can alveolar proteinosis be prevented?

There is currently no known definitive way to prevent primary AP, as its causes remain unknown. For secondary AP, preventing or managing underlying conditions may help lower the risk of developing this condition.

FAQs (Frequently Asked Questions)

What are the long-term consequences of untreated alveolar proteinosis?

Untreated AP can lead to chronic respiratory insufficiency, recurrent infections, and increased susceptibility to pulmonary fibrosis. In severe cases, it may result in disability or even death.

Can alveolar proteinosis be cured?

While there is no known cure for AP, treatments can help manage symptoms and improve lung function.

Is alveolar proteinosis contagious?

No, alveolar proteinosis is not contagious as it is not caused by an infection or a communicable disease.